Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3022475	b-mn	umol/l (—)	257	322	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm

112

3.91

21.59

1.4

1.2

—

Solid cancers, helper endpoint

111

3.89

21.11

1.4

1.2

—

Malignant neoplasm, wide definition for exclusion

117

3.76

20.75

1.4

1.2

—

Any event in cancer register

126

3.65

20.75

1.4

1.2

—

Other medical care

4.75

20.26

1.3

—

Malignant neoplasm of digestive organs

6.24

16.31

1.3

1.2

—

First line medication for Crohn's disease

144

2.97

15.11

1.4

1.2

—

Oxycodone

4.35

14.04

1.2

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

10.03

12.94

1.2

1.0

—

Malignant neoplasm of pancreas, including Hilmo

26.77

12.03

1.2

1.0

—

Persons encountering health services for specific procedures and health care

172

2.55

11.10

1.2

1.3

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

7.85

10.46

1.2

1.1

—

Liquid cancers, helper endpoint

4.47

8.83

1.5

1.2

—

Neoplasms

2.83

8.60

1.4

1.2

—

Any reimbursement code in KELA

2.72

6.49

1.4

1.2

—

Any death

105

2.59

6.46

1.1

1.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

4.05

6.26

1.1

1.2

—

malignant neoplasm of female genital organs

5.31

5.80

1.3

1.2

—

Other diseases of intestines

170

2.04

5.77

1.4

1.2

—

Malignant neoplasm of breast, HER-negative

4.91

5.75

1.1

—

Fever of other and unknown origin

121

2.50

5.71

1.2

1.4

—

Malignant neoplasm of breast, HER2-negative

2.73

5.51

1.3

1.2

—

ILD medications

178

1.95

5.32

1.4

1.2

—

Malaise and fatigue

2.55

5.29

1.1

1.4

—

Malignant neoplasm of breast

2.65

5.23

1.3

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

178

1.95

5.20

1.4

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.56

4.91

1.3

1.2

—

Malignant neoplasm of breast, including Hilmo

2.56

4.91

1.3

1.2

—

Certain disorders involving the immune mechanism

3.48

4.88

1.2

1.4

—

Malignant neoplasm of ovary

9.04

4.78

1.4

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

6.48

4.76

1.5

1.1

—

Noninfective enteritis and colitis

120

2.41

4.68

1.2

1.3

—

Malignant neoplasm of ovary, including Hilmo

7.17

4.65

1.4

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

142

1.94

4.49

1.2

1.3

—

Somatoform disorder

3.41

4.46

1.0

1.3

—

Other functional intestinal disorders

2.46

4.33

1.2

—

General symptoms and signs

148

1.90

4.29

1.1

1.3

—

Immunodeficiencies

11.70

4.27

1.0

1.5

—

Headache

140

2.11

4.23

1.1

1.3

—

Depression medications

3.66

4.22

1.4

—

Procreative management

2.44

4.15

1.6

1.2

—

GASTRO-related operations

2.10

4.13

1.3

1.2

—

Any gastric operation

2.10

4.13

1.3

1.2

—

Abnormalities of heart beat

2.61

3.98

1.4

—

Irritable bowel syndrome

2.67

3.98

1.1

1.2

—

Pain in throat and chest

140

1.93

3.84

1.1

1.3

—

Colorectal cancer

4.68

3.78

1.5

1.1

—

Anxiety disorders, excluding more controls

173

1.84

3.73

1.2

1.3

—

Anxiety disorders

193

1.81

3.63

1.2

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

197

1.79

3.57

1.2

1.3

—

Abdominal and pelvic pain

131

1.84

3.45

1.2

1.3

—

Hypothyroidism and >3 levothyroxin purchases

3.50

3.41

1.5

1.3

—

Hypothyroidism, levothyroxine purchases

3.50

3.41

1.5

1.3

—

Hypothyroidism (congenital or acquired)

3.50

3.40

1.5

1.3

—

Neurotic, stress-related and somatoform disorders

193

1.78

3.40

1.2

1.3

—

Biguanides

196

0.34

3.39

1.2

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

173

1.80

3.32

1.2

1.3

—

Triptan medication for migraine, single purchase ok

173

1.80

3.32

1.2

1.3

—

Chronic pancreatitis

4.35

3.30

1.1

1.6

—

Serous carcinoma of ovary, including Hilmo

8.61

3.26

1.3

1.0

—

Disorders of the thyroid gland

172

1.78

3.25

1.2

1.3

—

3.53

3.19

1.2

—

Malignant neoplasm of colon

5.34

3.19

1.6

1.0

—

Anaemias

3.73

3.15

1.1

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.96

3.13

1.2

1.4

—

Benign neoplasm: Transverse colon

4.51

3.11

1.3

1.5

—

Abnormalities of breathing

142

1.80

3.10

1.2

1.3

—

Nonorganic sleeping disorders, excluding more controls

2.80

3.08

1.2

1.3

—

L01XE Protein kinase inhibitors

7.52

3.05

1.3

1.4

—

Atrophic disorders of skin

3.17

3.05

1.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

5.01

3.05

1.1

1.3

—

Inflammatory bowel disease treatment related agents

192

1.66

3.03

1.3

1.2

—

Malignant neoplasm of colon, including Hilmo

4.28

2.99

1.8

1.1

—

Colorectal adenocarcinoma

4.28

2.98

1.6

1.1

—

Thyrotoxicosis, other and/or unspecified

2.75

2.98

1.2

—

Malignant neoplasm of kidney, except renal pelvis

10.01

2.98

1.6

1.0

—

Malignant neoplasm of urinary organs

10.01

2.98

1.6

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

174

1.73

2.96

1.2

1.3

—

Statin medication

177

0.38

2.95

1.7

1.2

—

Hypothyroidism, other/unspecified

165

1.75

2.94

1.2

1.3

—

Symptoms and signs involving the digestive system and abdomen

131

1.76

2.92

1.1

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

191

1.69

2.89

1.1

1.3

—

Budesonide

3.44

2.89

1.2

1.3

—

Lyme disease

2.29

2.83

1.1

1.3

—

Diseases of the eye and adnexa

125

1.76

2.82

1.3

1.2

—

Other disorders of skin and subcutaneous tissue

164

1.84

2.82

1.2

1.3

—

Hypothyroidism, drug reimbursement

4.24

2.80

1.2

1.4

—

Spirochaetal infections, other/unspecified

2.26

2.76

1.1

1.3

—

Other spirochaetal diseases

2.26

2.76

1.1

1.3

—

Malignant neoplasm of eye, brain and central nervous system

8.35

2.75

1.4

1.0

—

Abnormal blood-pressure reading, without diagnosis

8.35

2.75

1.0

1.5

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

8.34

2.75

1.6

1.0

—

Other diseases of biliary tract

5.01

2.72

1.3

1.2

—

Examination and observation for other reasons

1.91

2.72

1.3

1.2

—

Opioids

152

1.67

2.68

1.2

1.3

—

Other general symptoms and signs

5.95

2.68

1.2

1.6

—

Disorders of thyroid, IBD co-morbidities

2.57

2.63

1.2

—

Type 2 diabetes, wide definition

151

0.38

2.62

1.1

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

213

0.45

2.62

1.1

1.3

—

Heart failure, not strict

147

0.37

2.61

1.0

1.3

—

Malignant neoplasm of brain, including Hilmo

7.15

2.55

1.4

1.0

—

Colon adenocarcinoma

5.46

2.54

1.8

1.0

—

5-aminosalicylic acid

2.60

2.52

1.2

1.3

—

Other spirochaetal diseases

2.16

2.50

1.1

1.3

—

Generalized anxiety disorder

2.98

2.48

1.0

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.97

2.48

1.4

—

Use of pramipexole

2.55

2.44

1.2

1.4

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

197

0.46

2.41

1.1

1.3

—

Benzodiazepine use

206

1.60

2.40

1.2

1.3

—

Lichen sclerosus et atrophicus

3.34

2.39

1.2

1.3

—

Intestinal infectious diseases

192

1.58

2.39

1.1

1.3

—

Caries of dentine, including avohilmo

167

0.46

2.38

1.1

1.3

—

Malignant neoplasm of prostate

4.65

2.37

1.9

1.6

—

Dermatitis and eczema

205

1.57

2.36

1.2

1.3

—

Malignant neoplasm of prostate, including Hilmo

4.62

2.35

1.9

1.6

—

Sarcoidosis

3.03

2.35

1.3

1.5

—

Other (not insulin) diabetes medications

200

0.47

2.35

1.1

1.3

—

Nonorganic sleeping disorders

2.37

2.29

1.2

1.3

—

IBD patients in KELA-register

2.37

2.29

1.2

1.3

—

141

0.32

2.28

1.0

1.3

—

Placenta praevia

4.63

2.27

1.7

1.2

—

Substance abuse

148

0.32

2.26

1.0

1.3

—

Special screening examination for infectious and parasitic diseases

2.35

2.26

1.2

1.3

—

Haemangioma, any site

3.89

2.25

1.3

—

Haemangioma and lymphangioma, any site

3.89

2.25

1.3

—

Alcohol dependence

0.00

2.24

0.0

1.5

—

Gastrointestinal diseases

1.83

2.23

1.1

1.2

—

Mucosal proctocolitis

3.11

2.22

1.3

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.09

2.22

1.2

1.3

—

Dizziness and giddiness

171

1.67

2.17

1.3

—

Asthma and allergy

2.82

2.17

1.3

1.5

—

Mental disorders, not otherwise specified

3.69

2.15

1.0

1.4

—

Ulcerative colitis (strict definition, require KELA)

2.62

2.14

1.3

1.4

—

Other noninfective gastroenteritis and colitis

2.29

2.13

1.2

1.3

—

Asthma and allergy, excluding more controls

2.74

2.10

1.3

1.4

—

Family history of certain disabilities and chronic diseases leading to disablement

5.01

2.07

1.4

1.3

—

Family history of malignant neoplasm

2.91

2.07

2.0

1.3

—

Other viral diseases

2.13

2.06

1.4

1.3

—

Certain infectious and parasitic diseases

146

1.58

2.06

1.2

1.3

—

Other symptoms and signs involving the urinary system

3.50

2.05

1.0

1.5

—

Allergic rhinitis

2.02

2.04

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

4.00

2.04

1.0

1.4

—

Spirochaetal infections, other/unspecified

4.00

2.04

1.0

1.4

—

Mental and behavioural disorders due to psychoactive substance use

150

0.37

2.01

1.0

1.3

—

145

0.36

2.01

1.0

1.3

—

Hypothyroidism, strict autoimmune

134

1.67

2.01

1.2

1.3

—

Inflammatory bowel disease, strict (require KELA)

2.22

2.00

1.2

1.3

—

Oral corticosteroids

191

1.52

1.97

1.3

1.2

—

Other specified and unspecified personality disorders

3.34

1.96

1.0

1.4

—

Paralytic ileus and intestinal obstruction

2.35

1.94

1.7

1.4

—

Malignant neoplasm of thyroid gland

4.55

1.94

1.2

1.0

—

Thyroiditis, ILD-related definition

2.97

1.93

1.1

1.4

—

malignant neoplasm of male genital organs

3.55

1.93

1.9

1.4

—

Visual disturbances

127

1.81

1.93

1.3

—

Other antidepressants

153

1.54

1.90

1.2

1.3

—

Dyspnoea

195

1.55

1.89

1.2

1.3

—

Alcohol use disorder, Swedish definition

130

0.35

1.88

1.0

1.3

—

Medical observation and evaluation for suspected diseases and conditions

1.69

1.88

1.3

1.2

—

Fracture of skull and facial bones

0.00

1.87

0.0

1.3

—

Care involving use of rehabilitation procedures

145

1.71

1.87

1.1

1.3

—

Abnormal findings on diagnostic imaging of lung

102

1.88

1.87

1.3

—

Carpal tunnel syndrome

177

0.45

1.84

1.3

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

197

1.52

1.83

1.2

1.3

—

Ocular pain

3.53

1.83

1.0

1.5

—

Fentanyl

3.53

1.83

1.0

1.3

—

Periodontitis

213

0.53

1.83

1.0

1.3

—

Malignant neoplasm of thyroid gland, including Hilmo

4.17

1.82

1.2

1.0

—

Disorders of lacrimal system

115

1.82

1.80

1.2

1.3

—

Thyrotoxicosis

2.06

1.80

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.57

1.80

1.1

1.4

—

Pleural effusion

3.05

1.80

1.3

1.4

—

Malignant melanoma, including Hilmo

3.05

1.79

1.0

—

Injuries to the head

234

0.58

1.79

1.3

—

Noninfectious colitis NAS

2.76

1.79

1.0

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

110

0.36

1.77

1.2

1.3

—

Ulcerative colitis

2.17

1.77

1.2

1.3

—

Type 2 diabetes, strict (exclude DM1)

193

0.55

1.77

1.2

1.3

—

Persons encountering health services in other circumstances, wide

182

1.47

1.76

1.2

1.3

—

Substance abuse, excluding more controls

119

0.36

1.75

1.0

1.4

—

Other and unspecified drugs and medicaments

3.34

1.74

1.2

1.4

—

Malignant melanoma of skin, including Hilmo

3.34

1.74

1.0

—

Disturbances of skin sensation

1.98

1.74

1.2

1.3

—

Cough

1.89

1.72

1.2

1.4

—

Malignant neoplasm of endocrine gland

3.85

1.71

1.2

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

103

1.85

1.71

1.2

1.3

—

Coxarthrosis [arthrosis of hip](FG)

117

0.42

1.70

1.4

1.3

—

Pain (limb, back, neck, head abdominally)

1.65

1.70

1.4

1.3

—

Psoriasis vulgaris

0.00

1.70

0.0

1.4

—

Migraine without aura and triptan purchases

2.29

1.70

1.3

—

Pollen allergy

2.20

1.68

1.4

1.3

—

Missing teeth due to accident, extraction or parodontitis

152

0.43

1.66

1.0

1.3

—

Dental caries, including avohilmo

152

0.54

1.66

1.1

1.3

—

Other disorders of eye and adnexa

2.58

1.65

1.0

1.4

—

Colectomy operation

2.58

1.65

1.8

1.4

—

Visual disturbances and blindness

134

1.72

1.65

1.3

—

Agranulocytosis

2.80

1.65

1.1

1.5

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

175

1.61

1.64

1.4

1.2

—

Subjective visual disturbances

2.03

1.64

1.3

—

Myalgia

2.03

1.64

1.1

1.2

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2.44

1.64

1.3

1.4

—

Type 2 diabetes, definitions combined, including avohilmo

194

0.57

1.64

1.2

1.3

—

Sleep disorders

198

1.50

1.63

1.2

1.3

—

Scleritis and episcleritis

3.58

1.61

1.4

—

Disorders of mineral metabolism

3.57

1.61

1.2

—

Dysphagia

2.14

1.60

1.0

1.4

—

Chronic apical periodontitis

224

0.61

1.60

1.3

1.2

—

Other or unspecified ileus, impaction or obstruction

2.50

1.59

1.8

1.4

—

Chronic periodontitis, including avohilmo

212

0.57

1.59

1.0

1.3

—

Other external causes of accidental injury

136

1.51

1.59

1.3

1.2

—

Accidents

136

1.51

1.59

1.3

1.2

—

Insomnia

196

1.49

1.56

1.3

—

Type 2 diabetes, definitions combined

192

0.58

1.54

1.2

1.3

—

Vasomotor and allergic rhinitis

105

1.78

1.53

1.3

—

Intestinal stricture

2.03

1.53

1.6

1.3

—

Ethmoidectomy

2.43

1.53

1.1

1.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

171

1.50

1.53

1.2

1.3

—

Type 2 diabetes

205

0.60

1.53

1.1

1.3

—

Obsessive-compulsive disorder

3.34

1.52

1.2

1.4

—

Other headache syndromes

130

1.69

1.52

1.2

1.3

—

Endocrine, nutritional and metabolic diseases

131

1.51

1.3

—

Other benign neoplasms of connective and other soft tissue

2.86

1.50

1.5

1.4

—

Diseases of pulp and periapical tissues and dental caries

140

0.55

1.48

1.1

1.3

—

Voice disturbances

1.95

1.48

1.1

1.3

—

Intestinal infectious diseases

207

1.47

1.48

1.1

1.3

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.43

1.47

1.2

1.4

—

Mycoses

217

1.48

1.47

1.1

1.3

—

Other disorders of lacrimal gland

1.81

1.46

1.2

1.3

—

Coxarthrosis

105

0.44

1.46

1.4

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

160

1.49

1.46

1.2

—

Inflammatory bowel disease

1.84

1.45

1.2

1.3

—

Bacterial infection, other or unspecified

124

1.64

1.44

1.4

1.3

—

L02BA Anti-estrogens

2.12

1.44

1.8

1.2

—

Diabetes medication

219

0.62

1.44

1.1

1.3

—

Anogenital herpesviral [herpes simplex] infection

3.13

1.44

1.0

1.3

—

Thyroiditis

3.13

1.44

1.2

1.5

—

Other pleural conditions

3.13

1.44

1.2

1.3

—

Explicit bacterial Sepsis

3.13

1.44

1.8

1.3

—

Other complications of surgical and medical care, not elsewhere classified

2.73

1.43

1.2

1.4

—

Other and unspecified visual disturbances

2.73

1.43

1.7

1.3

—

Other metabolic disorders

2.31

1.43

1.1

1.3

—

Allergic conjunctivitis

183

1.54

1.42

1.4

1.2

—

Open wound of head

132

0.44

1.40

1.3

—

Unspecified acute lower respiratory infection

2.42

1.39

1.1

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

103

0.40

1.38

1.8

1.3

—

Polyp of the female genital tract

1.76

1.37

1.1

1.3

—

Haemorrhoids and perianal venous thrombosis

1.94

1.37

1.5

1.3

—

Later onset COPD

0.00

1.36

0.0

1.4

—

Used for control exclusion in common control thyroid runs

151

1.44

1.36

1.3

—

Sleep disorders (combined)

188

1.40

1.36

1.3

—

Malignant neoplasm of corpus uteri, including Hilmo

2.94

1.36

1.2

1.1

—

Enterocolitis due to Clostridium difficile

2.94

1.36

1.2

—

Infections, IBD-co-morbidities

2.22

1.35

1.2

1.3

—

Benign neoplasm: Colon

114

1.68

1.35

1.3

—

Alcohol abuse, main dg

0.00

1.34

0.0

1.4

—

Bacterial infection, other or unspecified

110

1.66

1.34

1.4

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

182

1.40

1.33

1.2

1.3

—

Episodal and paroxysmal disorders

183

1.39

1.33

1.2

1.3

—

All anxiety disorders

150

1.53

1.33

1.1

1.3

—

Female infertility

1.76

1.33

1.1

1.2

—

Conjunctivitis

200

1.46

1.32

1.3

1.2

—

Pain associated with micturition

2.50

1.30

1.3

1.5

—

Hypokalaemia

2.50

1.30

1.0

1.4

—

Post-traumatic stress disorder

2.78

1.28

1.2

1.3

—

Benign neoplasm of eye and adnexa

2.78

1.28

1.0

1.3

—

Social phobias

2.78

1.28

1.0

1.3

—

Exposure to unspecified factor

215

1.41

1.27

1.1

1.3

—

Pulmonary embolism

1.94

1.27

1.2

1.4

—

Pulmonary heart disease

1.94

1.27

1.2

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

200

1.42

1.27

1.3

—

Thyrotoxicosis with diffuse goitre

2.29

1.26

1.3

—

Single spontaneous delivery

0.46

1.26

2.1

1.2

—

Malignant neoplasm of breast, HER-positive

1.85

1.26

1.6

1.2

—

Autoimmune diseases related-to ILD

215

1.43

1.24

1.2

1.3

—

Obesity due to excess calories

157

0.51

1.24

1.0

1.3

—

Autoimmune diseases

164

1.40

1.24

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

145

1.54

1.23

1.2

1.3

—

Diabetes mellitus

214

0.66

1.23

1.1

1.3

—

Other diseases of upper respiratory tract

173

1.39

1.22

1.3

—

Persons encountering health services in circumstances related to reproduction

130

1.50

1.22

1.4

1.2

—

Diagnoses used for exclusion with ILD

1.97

1.22

1.3

1.4

—

Rash and other nonspecific skin eruption

2.63

1.21

1.0

1.5

—

Diabetes, varying definitions

214

0.66

1.21

1.1

1.3

—

Coxarthrosis, primary

123

0.48

1.21

1.4

1.3

—

Other heart diseases, wide

189

1.39

1.21

1.2

—

Functional dyspepsia

1.80

1.20

1.2

1.3

—

Viral and other specified intestinal infections

2.03

1.20

1.0

1.3

—

Certain infectious and parasitic diseases

100

1.50

1.19

1.1

1.3

—

Heart failure, strict

0.46

1.19

1.0

1.3

—

Postmenopausal atrophic vaginitis

1.80

1.17

1.3

1.2

—

Psoriatic arthropathies

0.00

1.16

0.0

1.4

—

Recurrent or chronic depression

1.62

1.15

1.0

1.3

—

Other viral diseases

109

1.64

1.15

1.4

1.3

—

Other anxiety disorders

122

1.56

1.15

1.1

1.3

—

Adjustment and management of implanted device

2.50

1.15

1.2

1.5

—

Disorders of conjunctiva

205

1.41

1.15

1.3

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

1.51

1.14

1.1

1.2

—

Alcohol abuse, main dg, excluding more controls

0.00

1.14

0.0

1.6

—

Dermatophytosis

166

1.50

1.14

1.2

1.3

—

Chronic periodontitis, complicated

150

0.53

1.13

1.0

1.3

—

Spontaneous abortion

125

0.54

1.13

1.3

1.2

—

Other diseases of intestine

2.33

1.12

1.4

—

External causes of morbidity and mortality

110

1.46

1.12

1.3

1.2

—

Phobic anxiety disorders

2.33

1.12

1.0

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

2.00

1.12

1.1

1.5

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.77

1.12

1.6

1.2

—

Excluding asthma or asthma-COPD overlap

131

1.41

1.11

1.1

1.3

—

COPD differential diagnosis

131

1.41

1.11

1.1

1.3

—

ILD differential diagnosis

131

1.41

1.11

1.1

1.3

—

Other bacterial intestinal infections

1.96

1.11

1.2

1.4

—

Symptoms and signs involving speech and voice

1.71

1.11

1.1

1.3

—

Disease of hard tissues of teeth, NOS

117

0.58

1.11

1.2

1.4

—

Primary gonarthrosis, bilateral

118

0.51

1.10

1.4

1.3

—

Pain in joint

1.54

1.09

1.3

—

Delivery

0.53

1.09

2.0

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

1.82

1.08

1.2

1.4

—

Congenital malformations and deformations of the musculoskeletal system

2.37

1.08

1.0

1.3

—

Complications of medical and surgical care

200

1.42

1.08

1.2

1.3

—

Polyarthropathies

152

0.60

1.07

1.4

1.3

—

All-cause Heart Failure

0.47

1.07

1.0

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

174

1.45

1.06

1.1

1.3

—

Allergic asthma (mode)

1.81

1.06

1.5

1.3

—

Allergic asthma (mode), excluding more controls

1.81

1.06

1.5

1.3

—

Nerve, nerve root and plexus disorders

216

0.68

1.06

1.5

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

151

0.61

1.05

1.3

—

Female infertility, cervical, vaginal, other or unspecified origin

1.68

1.05

1.1

1.2

—

Carcinoma in situ of breast, intraductal

2.27

1.03

1.4

1.2

—

Hydronephrosis

2.27

1.03

1.0

1.5

—

Benign neoplasm of breast

2.06

1.02

1.0

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

114

1.58

1.02

1.1

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.46

1.01

1.4

1.2

—

Reimbursement for rheumatic diseases

176

0.57

1.00

1.4

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

155

1.48

1.00

1.1

1.3

—

Later onset COPD, excluding more controls

0.00

0.99

0.0

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.86

0.99

1.1

1.3

—

Codes for special purposes

139

1.51

0.99

1.1

1.3

—

Provisional assignment of new diseases of uncertain etiology

139

1.51

0.99

1.1

1.3

—

Infectious mononucleosis

2.18

0.98

1.2

1.3

—

Sequelae of injuries of upper limb

2.18

0.98

1.6

1.1

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.97

0.0

1.3

—

Use of hypnotics and sedatives

190

1.33

0.97

1.1

1.3

—

Acute nasopharyngitis (common cold)

0.00

0.97

0.0

1.4

—

Other and unspecified polyneuropathies, also in other diseases

1.95

0.97

1.1

1.5

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.84

0.97

1.4

1.3

—

Cervicalgia

1.85

0.96

1.2

1.3

—

Other diseases of blood and blood-forming organs, wide

1.85

0.96

1.1

1.4

—

Psoriatic and enteropathic arthropathies

0.00

0.96

0.0

1.5

—

Migraine without aura

1.74

0.96

1.3

—

Exposure to other specified factors

205

1.39

0.96

1.1

1.3

—

Anxiety (asthma-related co-morbidities)

159

1.41

0.96

1.1

1.3

—

Benign neoplasms

159

1.35

0.96

1.4

1.3

—

Candidiasis

1.69

0.95

1.0

1.3

—

Dental operations

122

0.63

0.94

1.0

1.3

—

Basal cell carcinoma

1.81

0.94

1.4

1.2

—

Bacterial intestinal infections, IBD co-morbidities

1.89

0.94

1.3

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.64

0.93

1.0

1.4

—

Medical treatment for female infertility

1.68

0.93

1.2

—

Rotator cuff syndrome

133

0.59

0.92

1.7

1.2

—

Ischaemic heart disease, wide definition

138

0.63

0.92

1.6

1.2

—

Ventral hernia

1.82

0.92

1.1

1.4

—

Persons encountering health services in other circumstances

101

1.58

0.91

1.3

—

Myocardial infarction

0.47

0.91

1.6

1.3

—

Complications of surgical and medical care, not elsewhere classified

207

1.32

0.90

1.2

—

COPD

0.48

0.90

1.8

1.3

—

Aortic aneurysm

2.10

0.90

1.7

1.4

—

Other reaction to severe stress, and adjustment disorders

110

1.55

0.90

1.3

1.2

—

Other diseases of anus and rectum

1.74

0.89

1.5

1.3

—

Macular pucker

2.07

0.89

1.5

1.4

—

Injury of muscle and tendon at lower leg level

2.07

0.89

1.2

1.6

—

Sciatica+with lumbago

143

0.58

0.88

1.2

1.3

—

Fall on same level

203

1.29

0.88

1.3

1.2

—

Fracture of forearm

154

1.43

0.88

1.4

1.2

—

AV-block

2.02

0.87

1.2

1.4

—

Delivery, wide proxy

0.51

0.87

1.2

1.1

—

Other/unspecified synovitis and tenosynovitis

2.00

0.87

1.2

1.3

—

Hernia of abdominal wall, postoperative

2.00

0.87

1.2

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

198

1.32

0.86

1.3

1.2

—

Psychiatric diseases

160

1.31

0.86

1.2

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

132

1.45

0.86

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.75

0.86

1.5

1.2

—

Inguinal hernia

0.57

0.85

1.5

1.3

—

Angina pectoris

0.57

0.85

1.8

1.3

—

Major coronary heart disease event excluding revascularizations

0.56

0.85

1.9

1.3

—

FESS (DNB20)

1.94

0.84

1.2

1.5

—

Restless leg syndrome

1.94

0.84

1.0

1.5

—

Complications of procedures, not elsewhere classified

204

1.34

0.84

1.2

—

Other diseases of pleura

1.59

0.83

1.2

1.4

—

Diseases of oral cavity, salivary glands and jaws

118

0.65

0.83

1.0

1.3

—

Dental pulpitis, including avohilmo

209

0.71

0.83

1.2

1.3

—

Papulosquamous disorders

114

0.53

0.82

1.3

—

Varicose veins

135

0.61

0.82

1.1

1.2

—

Other symptoms and signs involving the digestive system and abdomen

1.74

0.82

1.4

1.2

—

Migraine

138

1.41

0.82

1.2

1.3

—

Appendectomy

196

1.37

0.82

1.2

1.3

—

Other viral diseases, not elsewhere classified

1.73

0.82

1.3

—

Other disorders of ear

195

0.70

0.82

1.2

1.3

—

Venous thromboembolism

125

1.47

0.81

1.5

1.2

—

Other/unspecified dorsalgia

104

1.53

0.81

1.2

1.3

—

Triptan medication for migraine, min. 3 purchases

156

1.37

0.81

1.2

—

Injuries to the shoulder and upper arm

201

0.68

0.81

1.4

1.3

—

In situ neoplasms

1.55

0.81

1.5

1.3

—

Non-invasive ventilation

1.65

0.81

1.2

1.3

—

Nausea and vomiting

1.68

0.80

1.2

1.4

—

Autoimmune diseases excluding thyroid diseases

163

1.31

0.79

1.2

1.3

—

Chronic sinusitis

122

1.47

0.79

1.2

—

Other arrhythmias

155

1.36

0.79

1.3

—

Thiazolidinediones

0.00

0.79

0.0

1.5

—

Cardiovascular diseases

114

1.37

0.79

1.4

1.2

—

Dermatitis

172

1.39

0.79

1.2

1.3

—

Female infertility, associated with anovulation

0.00

0.79

0.0

1.3

—

Other psoriatic arthropathies

0.00

0.79

0.0

1.5

—

Psoriatic arthropathies, ICD10

0.00

0.79

0.0

1.5

—

Obesity and other hyperalimentation

204

0.66

0.79

1.1

1.2

—

Obesity

204

0.66

0.78

1.1

1.2

—

Other chronic obstructive pulmonary disease

0.50

0.78

1.8

1.3

—

Abnormal serum enzyme levels

1.66

0.78

1.3

1.4

—

Cardiac arrhythmias

139

1.36

0.78

1.1

1.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.52

0.78

1.0

1.3

—

Glucagon-like peptide-1 (GLP-1) analogues

0.52

0.78

1.0

1.3

—

Extrapyramidal and movement disorders

1.59

0.78

1.0

1.4

—

Metatarsalgia

0.00

0.77

0.0

1.3

—

Arthropathic psoriasis

0.00

0.77

0.0

1.4

—

Chalazion

0.00

0.77

0.0

1.5

—

Polycystic ovarian syndrome, broad definition

0.00

0.77

0.0

1.2

—

DVT of lower extremities and pulmonary embolism

1.52

0.77

1.3

—

Menorrhagia

1.49

0.76

1.3

—

Benign neoplasm: Rectum

1.77

0.76

1.3

1.5

—

Other bacterial intestinal infections

1.77

0.76

1.3

1.5

—

Injury, poisoning and certain other consequences of external causes

1.39

0.76

1.3

1.2

—

Soft tissue disorders

173

1.28

0.76

1.3

1.2

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.76

0.0

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

200

0.75

0.76

1.3

—

Diseases of the skin and subcutaneous tissue

151

1.30

0.75

1.4

1.3

—

Cardiodefibrillation

1.69

0.75

1.2

1.4

—

Heartburn

2.08

0.74

1.0

1.5

—

Other and unspecified iron deficiency

1.57

0.74

1.4

1.3

—

2.00

0.72

1.0

1.2

—

Benign neoplasm of mouth and pharynx

2.00

0.72

1.4

—

Atopic dermatitis, strict definition

1.52

0.72

1.2

1.3

—

Fenamates

1.76

0.71

1.0

1.2

—

Pain, not elsewhere classified

1.58

0.71

1.1

1.4

—

Zoster [herpes zoster]

1.75

0.71

1.6

1.5

—

Benign neoplasm: Rectum, anus and anal canal

1.75

0.71

1.3

1.5

—

Anogenital herpesviral [herpes simplex] infection

1.92

0.70

1.0

1.2

—

Other bacterial diseases

200

1.27

0.70

1.3

—

Puerperal sepsis

1.71

0.70

1.0

1.3

—

Other acute lower respiratory infections

128

1.41

0.69

1.3

—

Supervision of normal pregnancy

0.52

0.69

1.0

1.1

—

Endometriosis

1.47

0.69

1.3

—

Other pulmonary diagnosis

131

1.30

0.68

1.1

1.3

—

Plantar fascial fibromatosis

1.85

0.68

1.0

1.3

—

Other disorders of breast

1.67

0.68

1.4

1.2

—

Zoster [herpes zoster]

133

1.41

0.68

1.3

—

COPD, hospital admissions

0.54

0.67

1.8

1.3

—

COPD, early/later onset

0.53

0.67

1.8

1.3

—

Falls/tendency to fall

185

1.25

0.67

1.4

1.2

—

Renal failure

0.54

0.67

1.0

1.4

—

Chronic diseases of tonsils and adenoids

156

1.30

0.66

1.3

1.2

—

Fracture of shoulder and upper arm

0.53

0.66

1.4

1.3

—

Gonarthrosis [arthrosis of knee](FG)

146

0.72

0.66

1.2

1.3

—

Viral pneumonia

1.79

0.66

1.0

1.6

—

Insulin medication

141

0.66

1.1

1.3

—

Congenital malformations and deformations of the musculoskeletal system

1.78

0.65

1.0

1.3

—

Pacemaker

1.60

0.65

1.3

—

Erosion of teeth , including avohilmo

1.57

0.65

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

171

1.34

0.65

1.2

1.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.61

0.65

1.2

—

Ischaemic Stroke, excluding all haemorrhages

0.61

0.65

1.4

1.3

—

Any mental disorder

177

1.24

0.65

1.1

1.3

—

Hallux valgus (acquired)

0.61

0.65

1.1

1.3

—

Pregnancy, childbirth and the puerperium

0.55

0.64

1.0

1.1

—

Deep bite

1.75

0.64

1.2

1.3

—

Other bacterial diseases

191

1.27

0.64

1.3

—

Periapical abscess

129

0.62

0.63

1.3

—

Constipation

185

1.27

0.63

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

0.56

0.63

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

1.47

0.63

1.2

1.3

—

Other arthrosis

123

0.68

0.62

1.1

1.3

—

Postpartum care and examination

1.62

0.62

1.1

—

Preterm labour and delivery

102

0.59

0.62

1.8

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

156

1.26

0.61

1.2

1.3

—

Gestational [pregnancy-induced] hypertension

104

0.58

0.61

1.3

1.2

—

Graves disease, strict definition

1.67

0.61

1.2

1.4

—

Other disorders of the musculoskeletal system and connective tissue

1.67

0.61

1.6

1.4

—

Pure hypercholesterolaemia

138

0.71

0.60

1.5

1.3

—

Amenorrhoea

0.00

0.60

0.0

1.2

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.60

0.0

1.4

—

Benign neoplasm: Caecum

0.00

0.60

0.0

1.3

—

Dilated cardiomyopathy

0.00

0.60

0.0

1.5

—

Spondylosis

124

0.66

0.60

1.1

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.57

0.60

1.0

1.3

—

Injury of muscle and tendon at hip and thigh level

0.00

0.60

0.0

1.3

—

Problems related to lifestyle

0.00

0.60

0.0

1.2

—

Malignant neoplasm of skin

1.52

0.60

1.4

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

111

0.68

0.59

1.2

—

Ptosis of eyelid

0.00

0.59

0.0

1.5

—

Cardiomyopathies, Primary/intrinsic

0.00

0.59

0.0

1.5

—

Cardiomyopathy (excluding other)

0.00

0.59

0.0

1.4

—

Gonarthrosis,primary

165

0.75

0.59

1.2

1.3

—

Endometriosis of pelvic peritoneum

1.53

0.59

1.5

1.2

—

Personality disorders, excluding more controls

1.53

0.59

1.0

1.4

—

Other obstructed labour

0.00

0.58

0.0

1.2

—

Other puerperal infections

0.00

0.58

0.0

1.1

—

Myocardial infarction, with ST-elevation

0.00

0.58

0.0

1.6

—

Peripheral arterial reconstruction

0.00

0.58

0.0

1.5

—

Supervision of high-risk pregnancy

0.56

0.58

1.0

1.1

—

Myopia

1.71

0.57

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

139

1.36

0.57

1.3

—

Neurological diseases

149

1.25

0.57

1.2

1.3

—

Leiomyoma of uterus

133

1.28

0.57

1.2

—

Other and unspecified dermatitis

149

1.34

0.57

1.2

1.3

—

Disorders of breast

159

1.31

0.57

1.2

—

Asthma (only as main-diagnosis)

131

1.28

0.57

1.4

1.3

—

Poor fetal growth

1.67

0.56

1.2

1.3

—

Asthma (diagnoses ohter than nonallergic)

219

1.25

0.56

1.4

1.2

—

Other systemic involvement of connective tissue

1.51

0.56

1.2

1.3

—

Basal cell carcinoma, including avohilmo

1.57

0.56

1.4

1.2

—

Infections with a predominantly sexual mode of transmission

1.43

0.56

1.1

1.3

—

Gingivitis and periodontal diseases

189

0.79

0.56

1.1

1.3

—

Asthma (mode)

131

1.27

0.55

1.4

1.3

—

Cholelithiasis

182

0.76

0.55

1.3

—

Transport accidents

108

0.64

0.55

1.6

1.3

—

Fitting and adjustment of other devices

1.50

0.54

1.0

1.5

—

Allergic contact dermatitis

1.58

0.54

1.2

1.3

—

Covid-19 confirmed case

1.46

0.54

1.1

1.3

—

Childhood asthma (age<16)

1.58

0.54

1.5

1.3

—

Childhood asthma (age<16), excluding more controls

1.58

0.54

1.5

1.3

—

Antenatal screening

0.58

0.53

1.0

1.1

—

Pain in limb

168

0.76

0.53

1.3

1.2

—

Labour and delivery complicated by fetal stress [distress]

0.59

0.53

1.0

1.2

—

Postmenopausal bleeding

1.49

0.53

1.3

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.45

0.53

1.0

1.2

—

Polyuria

1.54

0.53

1.0

1.5

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.45

0.53

1.7

1.3

—

Atopic dermatitis

153

1.29

0.52

1.3

—

Asthma, excluding more controls

129

1.25

0.51

1.4

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

1.50

0.51

1.0

1.4

—

Other diseases of hard tissues of teeth

118

0.75

0.51

1.0

1.3

—

Cerebrovascular diseases

135

0.73

0.50

1.2

1.3

—

Hernia of abdominal wall

109

1.38

0.50

1.1

1.3

—

Other systemic involvement of connective tissue (FG)

1.47

0.50

1.2

1.3

—

Disorders of synovium and tendon

149

1.29

0.50

1.0

1.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

143

0.70

0.50

1.1

1.3

—

Strabismus

1.46

0.50

1.3

—

Disorders of other endocrine glands

116

1.36

0.50

1.3

—

Speech therapy

1.49

0.49

1.0

1.3

—

Disorders of gallbladder, biliary tract and pancreas

192

1.21

0.49

1.2

1.3

—

Deforming dorsopathies

1.43

0.49

1.4

1.3

—

1.56

0.49

1.7

1.3

—

Propionic acid derivatives

1.49

0.49

1.4

1.2

—

Diseases of oesophagus, stomach and duodenum

204

1.20

0.49

1.2

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

1.49

0.48

1.1

1.4

—

Asthma

131

1.24

0.48

1.4

1.3

—

Disorders of eyelid, lacrimal system and orbit

198

1.23

0.48

1.2

1.3

—

COPD/asthma/ILD related infections

180

1.20

0.48

1.1

1.3

—

COPD/asthma related infections

180

1.20

0.48

1.1

1.3

—

Non-allergic asthma (mode), excluding more controls

1.51

0.48

1.1

1.4

—

Mood disorders, excluding more controls

177

1.21

0.47

1.0

1.3

—

Acute and subacute iridocyclitis

1.49

0.47

1.3

—

Gonarthrosis, primary, with knee surgery

123

0.71

0.46

1.4

1.3

—

Degeneration of macula and posterior pole

1.40

0.46

1.8

1.2

—

Heart failure and coronary heart disease

0.60

0.46

1.0

1.3

—

Unspecified lump in breast

1.46

0.46

1.1

1.2

—

Exclusions for E4_PCOS_BROAD

1.46

0.46

1.1

1.3

—

Non-allergic asthma (mode)

1.44

0.46

1.1

1.4

—

Bleeding

166

0.77

0.46

1.3

—

Hyperplasia of prostate

1.42

0.45

2.0

1.4

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

106

1.27

0.45

1.3

1.2

—

Diabetic retinopathy

1.41

0.45

1.4

1.1

—

Asthma (only as main-diagnosis), excluding more controls

129

1.24

0.45

1.4

1.3

—

Arthrosis

140

0.78

0.44

1.2

1.3

—

Concussion

127

1.28

0.44

1.3

—

Anterior Iridocyclitis

1.37

0.44

1.3

—

Neurological diseases, wide definition

1.38

0.43

1.2

—

Childhood allergy (age < 16)

1.65

0.43

1.4

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

141

1.22

0.43

1.3

1.2

—

Mood [affective] disorders

213

1.19

0.43

1.1

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

186

1.24

0.43

1.2

1.3

—

Candidiasis

1.61

0.43

1.0

1.4

—

Insulin, fast-acting or short human

0.66

0.42

1.0

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1.56

0.42

1.8

1.4

—

Melanocytic naevi

1.38

0.42

1.2

1.3

—

Effects of foreign body entering through natural orifice

1.40

0.42

1.6

1.4

—

Other dorsopathies, not elsewhere classified

172

1.19

0.42

1.3

—

Tooth eruption problems

1.52

0.41

1.0

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

1.38

0.41

1.5

1.3

—

Diplopia

1.52

0.41

1.0

1.4

—

Presbycusis

0.00

0.41

0.0

1.6

—

Pedestrian injured in transport accident

0.00

0.41

0.0

1.2

—

Benign neoplasm: Adrenal gland

0.00

0.41

0.0

1.2

—

Orchitis and epididymitis

0.00

0.41

0.0

1.4

—

Amiodarone users

0.00

0.41

0.0

1.6

—

Chronic viral hepatitis

0.00

0.41

0.0

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.41

0.0

1.3

—

Pyogenic arthritis

0.00

0.41

0.0

1.3

—

Synovial cyst of popliteal space [Baker]

0.00

0.41

0.0

1.3

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.41

0.0

1.2

—

Vitamin B12 deficiency anaemia

0.00

0.41

0.0

1.3

—

Iridocyclitis

1.36

0.41

1.3

—

Mood disorders

214

1.18

0.41

1.1

1.3

—

Inflammatory disease of cervix uteri

0.00

0.40

0.0

1.4

—

Other contact dermatitis

0.00

0.40

0.0

1.6

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.40

0.0

1.3

—

Volume depletion

0.00

0.40

0.0

1.4

—

Organic, including symptomatic, mental disorders

0.68

0.40

1.3

—

Injuries to the elbow and forearm

187

1.22

0.40

1.4

1.3

—

Rosacea

1.47

0.40

1.2

1.4

—

Calcific tendinitis of shoulder

0.00

0.40

0.0

1.3

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.40

0.0

1.3

—

Ovarian dysfunction

0.00

0.40

0.0

1.3

—

Ménière disease

0.00

0.40

0.0

1.3

—

Spontaneous rupture of synovium and tendon

0.00

0.40

0.0

1.3

—

Alcoholic liver disease

0.00

0.40

0.0

1.4

—

Stroke, excluding SAH

101

0.72

0.40

1.3

—

Other congenital malformations

1.43

0.39

1.0

1.3

—

Dorsopathies

173

1.18

0.39

1.3

—

All dysplastic lesions of the cervix uteri

104

0.67

0.39

1.0

1.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.39

0.0

1.3

—

Other soft tissue disorders, not elsewhere classified

173

1.19

0.39

1.3

1.2

—

Pregnancy with abortive outcome

136

0.81

0.38

1.0

1.2

—

Personality disorders

1.38

0.38

1.0

1.3

—

Other blood glucose lowering drugs, excl. Insulins

1.39

0.38

1.4

1.5

—

Panic disorder

1.39

0.38

1.0

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.41

0.37

1.5

1.3

—

Haemorrhage from respiratory passages

1.33

0.37

1.1

1.4

—

Other cataract

0.70

0.37

1.3

—

Low back pain

167

1.20

0.37

1.3

—

Fracture of foot, except ankle

1.32

0.37

1.1

1.3

—

Injuries to the knee and lower leg

211

1.16

0.37

1.1

1.3

—

Codeine

151

1.19

0.37

1.1

1.3

—

Radiculopathy

1.35

0.37

1.4

1.5

—

Acute pancreatitis (for exclusion)

1.35

0.37

1.4

1.5

—

Depression

208

1.17

0.37

1.1

1.3

—

Antihypertensive medication - note that there are other indications

123

1.21

0.36

1.4

1.3

—

Specific personality disorders

1.29

0.36

1.0

1.3

—

Explicit Sepsis

100

1.31

0.36

1.4

1.3

—

Spinal stenosis

103

0.74

0.36

1.0

1.3

—

Other and unspecified effects of external causes

1.36

0.36

1.2

1.3

—

Infections with a predominantly sexual mode of transmission

125

1.27

0.36

1.1

1.3

—

Injuries to the ankle and foot

192

1.20

0.36

1.1

1.3

—

Asthma/COPD (KELA code 203)

211

1.17

0.36

1.3

1.2

—

Paroxysmal tachycardia

0.63

0.36

1.2

—

Coronary atherosclerosis

100

0.76

0.35

1.5

1.3

—

Excessive attrition of teeth

179

0.78

0.35

1.2

1.3

—

Viral and other specified intestinal infections

1.38

0.35

1.0

1.3

—

Presence of other functional implants

1.27

0.35

1.1

1.3

—

Contraceptive management

107

1.25

0.34

1.3

1.2

—

Asthma, including avohilmo

210

1.15

0.34

1.4

1.2

—

Migraine with aura and triptan purchases

1.36

0.34

1.2

1.3

—

Single delivery by caesarean section

0.69

0.34

1.3

1.2

—

Diseases of the musculoskeletal system and connective tissue

1.22

0.34

1.3

1.2

—

Gonarthrosis

127

0.81

0.34

1.2

1.3

—

Other viral diseases, not elsewhere classified

1.36

0.33

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

175

1.19

0.33

1.2

1.3

—

Unspecified haematuria

0.68

0.33

1.2

1.4

—

Fracture at wrist and hand level

1.32

0.33

1.1

1.3

—

Other heart diseases

112

1.22

0.33

1.2

—

Noninflammatory disorders of female genital tract

1.25

0.33

1.3

—

Glaucoma suspect

0.69

0.33

1.0

1.3

—

Insulin, fast-acting

0.67

0.32

1.0

1.3

—

Other and unspecified disorders of vitreous body

108

1.28

0.32

1.6

1.2

—

Gastro-oesophageal reflux disease

173

1.20

0.32

1.1

1.3

—

Seborrhoeic keratosis

1.28

0.32

1.0

1.3

—

Cholelithiasis, broad definition with cholecystitis

185

0.84

0.32

1.3

—

Asthma, hospital admissions , main diagnosis only

218

1.17

0.32

1.4

1.2

—

Benign neoplasm of ovary

1.35

0.31

1.1

1.2

—

Dorsalgia

172

1.15

0.31

1.3

—

Long labour

0.70

0.30

1.3

1.2

—

Unspecified fall

129

0.76

0.30

1.1

1.3

—

Acute sinusitis

153

1.21

0.30

1.3

—

Nonsuppurative otitis media

1.29

0.30

1.6

1.3

—

Disorders of skin appendages

147

1.22

0.30

1.1

1.3

—

Other female pelvic inflammatory diseases

1.27

0.30

1.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

1.27

0.30

1.0

1.4

—

Fibroblastic disorders

1.27

0.30

1.0

1.3

—

Anomalies of dental arch relationship, including avohilmo

1.26

0.29

1.1

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

170

1.19

0.29

1.0

1.3

—

Sensorineural hearing loss

148

0.83

0.29

1.1

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

111

1.26

0.29

1.1

1.3

—

Primary open-angle glaucoma

1.23

0.29

1.3

1.4

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.23

0.29

1.1

1.3

—

Haemorrhage in early pregnancy

107

0.73

0.28

1.4

1.2

—

Diseases of the digestive system

109

0.73

0.28

1.3

—

Shoulder lesions

145

0.84

0.28

1.6

1.2

—

Atrial fibrillation and flutter

1.28

0.28

1.2

—

Stroke, including SAH

110

0.79

0.28

1.2

1.3

—

Coxibs

1.24

0.28

1.0

1.2

—

Endometriosis ASRM stages 1,2

1.27

0.27

1.5

1.3

—

Mycoses

1.27

0.27

1.1

1.4

—

Persons encountering health services for examination and investigation

1.19

0.27

1.4

1.2

—

Other strabismus

1.27

0.27

1.4

1.3

—

Covid-19 suspected case

1.25

0.27

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.23

0.27

1.2

—

Obesity, other/unspecified

118

0.76

0.27

1.1

1.3

—

Acute tubulo-interstitial nephritis

158

0.82

0.27

1.2

1.3

—

Osteopathies and chondropathies

139

1.21

0.27

1.3

—

Valvular heart disease excluding rheumatic fever

0.78

0.27

1.4

1.3

—

Injuries to the neck

1.23

0.27

1.0

1.3

—

Pregnancy hypertension

144

0.81

0.26

1.3

1.2

—

Maternal care for known or suspected malpresentation of fetus

0.66

0.26

1.0

1.2

—

Unstable angina pectoris

0.67

0.26

1.8

1.4

—

Cystitis

172

1.14

0.26

1.2

1.3

—

Anti-inflammatory and antirheumatic products, non-steroids

1.22

0.26

1.3

1.2

—

Conduction disorders

1.26

0.26

1.3

—

Finngen Rheumatological endpoints

197

1.13

0.25

1.3

—

Non-rheumatic valve diseases

0.78

0.25

1.4

1.3

—

Senile cataract

105

0.82

0.25

1.7

1.3

—

Other nutritional deficiencies

201

0.84

0.25

1.1

1.3

—

Diseases of the respiratory system

112

1.16

0.25

1.2

1.3

—

Polycystic ovarian syndrome, consortium definition

165

0.86

0.25

1.2

—

1.21

0.25

1.4

1.3

—

Oedema, not elsewhere classified

1.22

0.25

1.1

1.4

—

Caries of enamel

203

1.14

0.25

1.2

1.3

—

Benign paroxysmal vertigo

1.20

0.25

1.4

—

Acute appendicitis

209

0.85

0.25

1.1

1.3

—

Lumbar disc prolapse

155

0.84

0.24

1.2

1.3

—

Disorders of adult personality and behaviour

1.26

0.24

1.0

1.3

—

Second line medication for Crohn's disease

180

0.83

0.24

1.4

1.2

—

Conductive and sensorineural hearing loss

158

0.85

0.24

1.1

1.3

—

Septicaemia

1.25

0.24

1.2

1.3

—

Iron deficiency anaemia

104

1.23

0.23

1.4

1.3

—

Female genital prolapse

1.26

0.23

1.2

—

Diseases of male genital organs

0.72

0.23

2.0

1.4

—

Vocal cord dysfunction

1.32

0.23

1.8

1.3

—

Disorders of choroid and retina

158

0.85

0.23

1.5

1.2

—

Obesity related asthma

1.24

0.22

1.2

—

Acute upper respiratory infections

204

1.12

0.22

1.1

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.77

0.22

1.1

1.3

—

Abnormalities of forces of labour

1.25

0.22

1.6

1.2

—

Benign mammary dysplasia

1.25

0.22

1.0

1.2

—

Obstructed labour due to malposition and malpresentation of fetus

0.74

0.22

1.3

1.2

—

All chronic kidney diseases

111

0.81

0.22

1.0

1.3

—

Factors influencing health status and contact with health services

1.29

0.22

1.0

1.3

—

Hypertension

161

0.88

0.22

1.5

1.2

—

Hypertensive diseases

161

0.88

0.22

1.5

1.2

—

Persons with potential health hazards related to communicable diseases

115

1.21

0.22

1.1

1.3

—

Maternal care for other known or suspected fetal problems

0.77

0.21

1.1

1.2

—

Insulin, intermediate and long-acting

131

0.82

0.21

1.1

1.3

—

Acute pancreatitis

1.19

0.21

1.4

1.5

—

Mental retardation, wide definition

0.00

0.21

0.0

1.4

—

Other maltreatment syndromes

0.00

0.21

0.0

1.3

—

Mental and behavioural disorders due to cannabinoids

0.00

0.21

0.0

1.0

—

Astigmatism

0.00

0.21

0.0

1.4

—

Arthropathies in other diseases classified elsewhere

0.00

0.21

0.0

1.3

—

Hidradenitis suppurativa

0.00

0.21

0.0

1.5

—

Burn and corrosion of wrist and hand

0.00

0.21

0.0

1.3

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.2

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.21

0.0

1.0

—

Congenital malformations of aortic and mitral valves

0.00

0.21

0.0

1.3

—

Contusion of ankle

0.00

0.21

0.0

1.4

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

1.3

—

Benign neoplasm: Skin of trunk

0.00

0.21

0.0

1.3

—

Optic neuritis

0.00

0.21

0.0

1.5

—

Other diseases of peritoneum

0.00

0.21

0.0

1.3

—

Monoarthritis, not elsewhere classified

0.00

0.21

0.0

1.3

—

Other abnormal findings of blood chemistry

0.00

0.21

0.0

1.3

—

Varicella [chickenpox]

0.00

0.21

0.0

1.3

—

Cirrhosis of liver, NAS

0.00

0.21

0.0

1.3

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.7

—

Impotence

0.00

0.21

0.0

1.5

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

1.5

—

Urethral stricture

0.00

0.21

0.0

1.8

—

Sequelae of other external causes

0.00

0.21

0.0

1.3

—

Additional codes for the location of defect, injury or illness

0.00

0.21

0.0

1.3

—

Other necrotizing vasculopathies (FG)

0.00

0.21

0.0

1.3

—

Lichen simplex chronicus and prurigo

0.00

0.21

0.0

1.5

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Manganese [Moles/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS